As of August 29, 2026, Roivant Sciences's top three insider holders are Pharma Technologies Ltd. Dexcel (TenPercentOwner, 102.85Mn shares), Investments (Uk) Ltd Svf (TenPercentOwner, 73.03Mn shares), Investments (Uk) Ltd Svf (TenPercentOwner, 73.03Mn shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Pharma Technologies Ltd. Dexcel | TenPercentOwner | 102,849,443 | 0 | 102,849,443 | 25.7% | 14 Nov, 2022 |
| 2 | Investments (Uk) Ltd Svf | TenPercentOwner | 0 | 73,031,667 | 73,031,667 | 18.2% | 02 Oct, 2023 |
| 3 | Chemical Co., Ltd. Sumitomo | TenPercentOwner | 0 | 71,251,083 | 71,251,083 | 17.8% | 26 Jun, 2023 |
| 4 | Vivek Ramaswamy | TenPercentOwner | 33,653,755 | 0 | 33,653,755 | 8.4% | 15 Dec, 2025 |
| 5 | Mayukh Sukhatme | President Cio | 18,630,739 | 0 | 18,630,739 | 4.6% | 21 Aug, 2026 |
| 6 | Matthew Gline | Ceo | 16,659,945 | 0 | 16,659,945 | 4.2% | 02 Jul, 2026 |
| 7 | Keith S Manchester | Director | 1,748,403 | 13,689,166 | 15,437,569 | 3.9% | 30 Jun, 2026 |
| 8 | Financial Lp Qvt | Other | 0 | 13,689,166 | 13,689,166 | 3.4% | 30 Jun, 2026 |
| 9 | Daniel Allen Gold | Director | 0 | 13,689,166 | 13,689,166 | 3.4% | 30 Jun, 2026 |
| 10 | Frank Torti | President And Vant Chair | 13,536,202 | 0 | 13,536,202 | 3.4% | 02 Jul, 2026 |
| 11 | Global Investors Lp Viking | TenPercentOwner | 0 | 12,884,307 | 12,884,307 | 3.2% | 26 Jun, 2023 |
| 12 | Global Performance Llc Viking | TenPercentOwner | 0 | 12,884,307 | 12,884,307 | 3.2% | 26 Jun, 2023 |
| 13 | Eric Venker | President Immunovant Ceo | 1,599,154 | 0 | 1,599,154 | 0.4% | 01 Sep, 2026 |
| 14 | Richard Pulik | Cfo | 271,810 | 0 | 271,810 | 0.1% | 24 Aug, 2026 |
| 15 | Rakhi Kumar | Chief Accounting Officer | 162,306 | 0 | 162,306 | 0.0% | 24 Feb, 2025 |
| 16 | Ilan Oren | Director | 121,004 | 0 | 121,004 | 0.0% | 21 Jul, 2026 |
| 17 | James C Momtazee | Director | 109,810 | 0 | 109,810 | 0.0% | 21 Jul, 2026 |
| 18 | Jennifer Humes | Chief Accounting Officer | 109,782 | 0 | 109,782 | 0.0% | 23 Jun, 2026 |
| 19 | Andrew Lo | Director | 52,142 | 0 | 52,142 | 0.0% | 19 Sep, 2022 |
| 20 | Meghan Fitzgerald | Director | 42,963 | 0 | 42,963 | 0.0% | 02 Jul, 2026 |
| 21 | Melissa B, Epperly | Director | 17,017 | 0 | 17,017 | 0.0% | 21 Jul, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 28 Aug, 2026 | Eric Venker | President Immunovant Ceo | Acquired M | 200,000 | $3.85 | $770.00K | 1,799,154 | Direct |
| 28 Aug, 2026 | Eric Venker | President Immunovant Ceo | Disposed S | 166,182 | $35.63 | $5.92Mn | 1,632,972 | Direct |
| 28 Aug, 2026 | Eric Venker | President Immunovant Ceo | Disposed S | 33,818 | $36.44 | $1.23Mn | 1,599,154 | Direct |
| 28 Aug, 2026 | Eric Venker | President Immunovant Ceo | Disposed M | 200,000 | $0.00 | $0 | 3,844,834 | Direct |
| 20 Aug, 2026 | Richard Pulik | Cfo | Disposed F | 5,749 | $36.84 | $211.79K | 271,810 | Direct |
| 20 Aug, 2026 | Eric Venker | President Immunovant Ceo | Disposed F | 13,909 | $36.84 | $512.41K | 1,599,154 | Direct |
| 19 Aug, 2026 | Mayukh Sukhatme | President Cio | Acquired M | 172,899 | $3.85 | $665.66K | 18,803,638 | Direct |
| 19 Aug, 2026 | Mayukh Sukhatme | President Cio | Disposed S | 172,899 | $37.17 | $6.43Mn | 18,630,739 | Direct |
| 20 Aug, 2026 | Mayukh Sukhatme | President Cio | Acquired M | 17,519 | $3.85 | $67.45K | 18,648,258 | Direct |
| 20 Aug, 2026 | Mayukh Sukhatme | President Cio | Disposed S | 17,519 | $37.30 | $653.46K | 18,630,739 | Direct |
| 21 Aug, 2026 | Mayukh Sukhatme | President Cio | Acquired M | 144,756 | $3.85 | $557.31K | 18,775,495 | Direct |
| 21 Aug, 2026 | Mayukh Sukhatme | President Cio | Disposed S | 144,756 | $36.48 | $5.28Mn | 18,630,739 | Direct |
| 19 Aug, 2026 | Mayukh Sukhatme | President Cio | Disposed M | 172,899 | $0.00 | $0 | 13,386,638 | Direct |
| 20 Aug, 2026 | Mayukh Sukhatme | President Cio | Disposed M | 17,519 | $0.00 | $0 | 13,369,119 | Direct |
| 21 Aug, 2026 | Mayukh Sukhatme | President Cio | Disposed M | 144,756 | $0.00 | $0 | 13,224,363 | Direct |
| 14 Aug, 2026 | Mayukh Sukhatme | President Cio | Acquired M | 243,177 | $3.85 | $936.23K | 18,873,916 | Direct |
| 14 Aug, 2026 | Mayukh Sukhatme | President Cio | Disposed S | 243,177 | $36.23 | $8.81Mn | 18,630,739 | Direct |
| 17 Aug, 2026 | Mayukh Sukhatme | President Cio | Acquired M | 284,707 | $3.85 | $1.10Mn | 18,915,446 | Direct |
| 17 Aug, 2026 | Mayukh Sukhatme | President Cio | Disposed S | 284,707 | $36.25 | $10.32Mn | 18,630,739 | Direct |
| 18 Aug, 2026 | Mayukh Sukhatme | President Cio | Acquired M | 105,141 | $3.85 | $404.79K | 18,735,880 | Direct |